Angel Biotech (LON:ABH), the biopharmaceutical contract manufacturer, has signed a revised, longer-term contract with fellow AIM company Reneuron (LON:RENE) that will see it provide development and ...
ReN001, which is derived from a neural stem cell line, is in a Phase I stroke trial. Angel Biotechnology signed a contract with ReNeuron to perform development and GMP manufacturing services to ...
Angel Biotechnology Holdings plc, (AIM:ABH), the biopharmaceutical contract manufacturer, is pleased to announce with immediate effect the acquisition of the assets of an established biomaterial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback